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Introduction
Despite the fact that some states have legalized medical marijuana,
disabled employees are being fired for using it. Gary Ross, disabled from
injuries suffered while he served in the United States Air Force, began
using medical marijuana after traditional medications failed to alleviate
his pain.1 Joseph Casias used medical marijuana to alleviate pain caused
by sinus cancer and an inoperable brain tumor.2 Brandon Coats, a quadriplegic, used medical marijuana to control painful muscle spasms

1.

Ross v. RagingWire Telecomms., Inc., 174 P.3d 200, 203 (Cal. 2008).

2.

Casias v. Wal-Mart Stores, Inc., 695 F.3d 428, 431 (6th Cir. 2012).
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caused by his paralysis.3 All of these employees were fired when their
employers found out that they used marijuana.4
How can someone be fired for using a drug that is authorized by
state law? Normally, the federal Americans with Disabilities Act (ADA)
would protect disabled persons that use legally prescribed drugs from
employment discrimination that stems from that drug use. But the
ADA does not protect users of illegal drugs, and marijuana is illegal
under federal law. 5 Thus, the ADA does not protect disabled medical
marijuana users when they are fired for violating workplace drug testing
policies.
Medical marijuana users have tried suing their employers under the
theory that state medical marijuana laws protect employees from the
consequences of violating drug-free workplace policies.6 But, in the
absence of explicit statutory language granting employment protection
to medical marijuana users, the courts refuse to rule in favor of the
employees. Court decisions favoring employers place a substantial
burden on medical marijuana patients—choosing between “giving up
what may be their only source of income, or . . . discontinu[ing] marijuana treatment, and try[ing] to endure their chronic pain or other
condition for which marijuana may provide the only relief.”7 A clearly
drafted statutory provision that prevents employers from using medical
marijuana users’ drug use as a reason to terminate them will alleviate
the burden that employees currently bear.
Part I of this Note gives a brief history of marijuana regulation in
the United States. Part II describes how drug testing works and why
employers do it. And it presents some of the issues that the federal
prohibition poses for employers and employees. Part III analyzes state
court opinions that have addressed the question of whether employers
may fire employees for off-site medical marijuana use that does not
3.

Opening Brief at 18, Coats v. Dish Network, LLC, 350 P.3d 849 (Colo. 2015),
(No. 2013SC000394).

4.

Ross, 174 P.3d at 203; Casias, 695 F.3d at 432; Coats v. Dish Network,
LLC, 303 P.3d 147, 149 (Colo. App. 2013), aff’d, 350 P.3d 849 (Colo. 2015).

5.

See 42 U.S.C. § 12210(a) (2012) (“For purposes of this chapter, the term
‘individual with a disability’ does not include an individual who is
currently engaging in the illegal use of drugs, when the covered entity acts
on the basis of such use.”); 42 U.S.C. § 12111(6) (2012) (defining “illegal
use of drugs” as a use of a Schedule I-V controlled substance unless the
substance is “taken under supervision by a licensed health care professional” or otherwise authorized by federal law); see also Russell Rendall,
Medical Marijuana and the ADA: Removing Barriers to Employment for
Disabled Individuals, 22 Health Matrix 315, 324–325 (2012) (describing
two federal court decisions that held that medical marijuana is illegal for
the purposes of the ADA).

6.

See, e.g., Ross, 174 P.3d at 204; Casias, 695 F.3d at 432.

7.

Ross, 174 P.3d at 211 (Kennard, J., concurring and dissenting).

210

Case Western Reserve Law Review·Volume 66·Issue 1·2015
Protecting Medical Marijuana Users in the Workplace

impair work performance. Every court thus far has ruled in favor of the
employer, but some of the opinions and dissents acknowledge that the
legislatures could amend their states’ statutes to include employment
protections for medical marijuana users. Part IV analyzes the strengths
and weaknesses of the state medical marijuana laws that include some
form of employment protection. Finally, Part V proposes statutory
language that could be included in state medical marijuana laws to
protect employees from termination simply because of their authorized
use of marijuana.

I.

Marijuana Regulation Since the 1970s

Marijuana is illegal under federal law.8 But its legal status in the
states is rapidly changing. Twenty-three states, as well as the District
of Columbia, currently allow medical marijuana.9 Four states and D.C.
also allow marijuana for recreational use.10 The change in state laws
reflects the public’s changing opinion on marijuana.11 Federal law,
however, remains unchanged. The federal Controlled Substances Act
(CSA) classifies marijuana as a Schedule I substance, meaning that
marijuana has no medicinal value and high potential for abuse.12
Because the drafters of the CSA had limited knowledge of
marijuana, they created the National Commission on Marihuana and
Drug Abuse (Commission) to study marijuana and submit a report to
Congress with its findings and recommendations.13 Congress mandated
that the Commission research (1) the prevalence of marijuana use in
the United States, (2) “the efficacy of existing marihuana laws,” (3) the
physiological and psychological long-term effects of marijuana, (4) the
8.

21 U.S.C. §§ 812(c)(c)(10), 841(a) (2012).

9.

The states are Alaska, Arizona, California, Colorado, Connecticut,
Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan,
Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico,
New York, Oregon, Rhode Island, Vermont, and Washington. State
Medical Marijuana Laws, Nat’l Conference of State Legislatures
(Sept. 14, 2015), http://www.ncsl.org/research/health/state-medicalmarijuana-laws.aspx [https://perma.cc/2AMD-9U6A].

10.

The states are Alaska, Colorado, Oregon, and Washington. Id.

11.

A Pew Research Center survey conducted October 15–20, 2014, reported
that 52% of Americans support legalizing marijuana and only 45% oppose.
Slim Majority Supports Marijuana Legalization, Pew Research Ctr.
(Oct. 23, 2014), http://www.people-press.org/2014/10/23/as-midtermsnear-gop-leads-on-key-issues-democrats-have-a-more-positive-image/slimmajority-supports-marijuana-legalization/ [https://perma.cc/R9ZK-S4BE].

12.

21 U.S.C. § 812(b)(1)(A)–(B) (2012).

13.

Establishment of Commission on Marihuana and Drug Abuse, Pub. L.
No. 91-513, § 601(e), 84 Stat. 1280, 1281 (1970).
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relationship between marijuana use and aggression and crime, (5) “the
relationship between marihuana and the use of other drugs,” and (6)
“the international control of marihuana.”14
The Commission released its report, Marihuana: A Signal of
Misunderstanding (Report), in 1972.15 After conducting over fifty
projects,16 the Commission rejected the federal government’s total
prohibition policy on marijuana.17 The Report stated that “[t]his policy
grew out of a distorted and greatly exaggerated concept of the drug’s
ordinary effects upon the individual and the society.”18 The Report
recommended instead a policy of decriminalization pending more
research on marijuana.19 Congress did not listen to the Commission’s
recommendations and has kept marijuana as a Schedule I substance.
Despite the Commission’s recommendation to continue researching
marijuana, those who wish to do so face significant obstacles in the
United States.20 The only federally legal source for researchers to obtain
marijuana is a twelve-acre plot at the University of Mississippi,
controlled by the National Institute on Drug Abuse.21 To access this
marijuana, researchers must gain approval from a number of federal
administrative agencies.22 Between 1999 and June 2015, only sixteen independently funded studies obtained marijuana through this process.23

14.

Id. § 601(d)(1)(A)–(F), 84 Stat. at 1281.

15.

Nat’l Comm’n on Marihuana and Drug Abuse, Marihuana: A
Signal of Misunderstanding (1972) [hereinafter Report].

16.

Id. at 2.

17.

Id. at 175.

18.

Id. at 162.

19.

Id. at 189. See also Gerald F. Uelmen & Alex Kreit, Drug Abuse
and the Law Sourcebook § 3:73, Westlaw (database updated Nov.
2014) (explaining that the Commission “unanimously recommended a
social policy of marijuana discouragement: specifically not legalization, as
with the alcohol or tobacco models, but also no imprisonment for
possession of marijuana for personal use (i.e., ‘decriminalization’)”).

20.

Report, supra note 15, at 219; Uelmen & Kreit, supra note 19, at § 1:27.

21.

Id. See also David Kelly, Colorado Seeks Permission to Grow Pot at
State Universities, L.A. Times, Jan. 25, 2015, http://www.latimes.com/nation/
la-na-pot-research-20150125-story.html [https://perma.cc/P5Y2-FTUF].

22.

FDA and Marijuana, Food and Drug Admin., http://www.fda.gov/
NewsEvents/PublicHealthFocus/ucm421163.htm [http://perma.cc/VB54CSMD] (last updated Mar. 3, 2015).

23.

Independently Funded Studies Receiving Research Grade Marijuana, Nat’l
Inst. on Drug Abuse, http://www.drugabuse.gov/drugs-abuse/marijuana/
independently-funded-studies-receving-research-grade-marijuana-1999to-present [http://perma.cc/6327-2UZ8] (last updated July 2015).
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This process is “complicated” and does not fulfill the demand for
medical marijuana research.24
Along with research from other countries and analysis of selfreported data, the results of the FDA-approved clinical marijuana
studies, suggest that marijuana does have a medicinal value, despite its
Schedule I classification. The research suggests that marijuana can
benefit persons suffering from a myriad of conditions, including chronic
pain,25 epilepsy,26 spasticity,27 and cancer.28 While the growing body of
research on marijuana’s beneficial therapeutic uses has not swayed the
FDA or DEA to reschedule marijuana, it has swayed voters and
24.

A policy paper released by the American College of Physicians states that
“[u]nfortunately, research expansion has been hindered by a complicated
federal approval process, limited availability of research-grade marijuana,
and the debate over legalization.” Tia Taylor, Am. Coll. of
Physicians, Supporting Research Into the Therapeutic Role of
Marijuana 1 (2008). Similarly, the American Medical Association’s
policy statement on medical marijuana encourages further research on
marijuana’s therapeutic effects. H-95.952 Cannabis for Medicinal Use,
Am. Med. Ass’n, https://www.ama-assn.org/ssl3/ecomm/PolicyFinder
Form.pl?site=www.ama-assn.org&uri=/resources/html/PolicyFinder/
policyfiles/HnE/H-95.952.HTM [https://perma.cc/3RQS-K6VT]
(last visited Sept. 28, 2015).

25.

See Mary E. Lynch & Fiona Campbell, Cannabinoids for Treatment of
Chronic Non-Cancer Pain; A Systematic Review of Randomized Trials,
72 Brit. J. Clinical Pharmacology 735, 742 (2011) (conducting a
review of eighteen randomized control trials that tested the efficacy of
marijuana as treatment for chronic pain and finding that marijuana is a
“modestly effective and safe treatment option for chronic non-cancer
(predominantly neuropathic) pain”).

26.

See Brenda E. Porter & Catherine Jacobson, Report of a Parent Survey
of Cannabidiol-Enriched Cannabis Use in Pediatric Treatment-Resistant
Epilepsy, 29 Epilepsy & Behav. 574, 575 (2013) (finding that parents
that treat their children’s epilepsy with certain strains of marijuana report
a “high rate of success in reducing seizure frequency with this treatment”);
Jack Healy, Families See Colorado as New Frontier on Medical
Marijuana, N.Y. Times, Dec. 5. 2013, http://www.nytimes.com/2013/
12/06/us/families-see-colorado-as-new-frontier-on-medical-marijuana.
html?_r=0 [https://perma.cc/ZCW8-P5J9] (describing how families are
moving to Colorado to treat their children’s seizures with marijuana).

27.

See Jody Corey-Bloom et al., Smoked Cannabis for Spasticity in Multiple
Sclerosis: A Randomized, Placebo-Controlled Trial, 184 Canadian Med.
Ass’n J. 1143, 1145 (2012) (administering marijuana to patients with multiple
sclerosis and spasticity resulted in a “clinically meaningful” reduction in pain).

28.

Clinical (human) trials on marijuana and cancer show that marijuana can help
with nausea, appetite stimulation, pain relief, anxiety, and sleep. See Cannabis
and Cannabinoids, Nat’l Cancer Inst. http://www.cancer.gov/aboutcancer/treatment/cam/patient/cannabis-pdq#section/all [https://perma.cc/
P2GN-B45W] (last updated July 16, 2015). Pre-clinical (laboratory or animal)
studies show that marijuana might also promote antitumor activity. Id.
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legislators in twenty-three states to make marijuana available for
medical use.29
Federal enforcement of the CSA in the twenty-three states that
have legalized medical marijuana is weak. In 2009 Deputy Attorney
General David Ogden released a memo addressed to federal prosecutors
saying that prosecution of seriously ill individuals using marijuana in
compliance with state law was an inefficient use of federal resources.30
Deputy Attorney James Cole reaffirmed the Ogden Memo in 2011. 31 In
2013, Cole issued another memo offering more guidance to federal prosecutors on how to treat state law–compliant medical marijuana users.32
In the Memo, Cole outlined the following eight enforcement priorities:
(1) keeping marijuana away from minors, (2) preventing criminal enterprises from profiting from medical marijuana, (3) restricting marijuana
diversion from one state to another, (4) ensuring that legal marijuana
activity is not a pretext for illegal activity, (5) preventing violence and
gun activity in marijuana growing, (6) preventing drugged driving and
other adverse public health consequences, (7) protecting federal land,
and (8) keeping marijuana off of federal property.33 Outside of these
eight priorities, the Department of Justice “has traditionally relied on
states and local law enforcement agencies to address marijuana activity
through enforcement of their own narcotics laws.”34
In December 2014, Congress passed an omnibus spending bill that
prohibited use of federal funds to interfere with state medical marijuana
laws.35 That meant that for the 2015 fiscal year the Department of
29.

State Medical Marijuana Laws, Nat’l Conference of State
Legislatures (Sept. 14, 2015), http://www.ncsl.org/research/health/
state-medical-marijuana-laws.aspx [https://perma.cc/2AMD-9U6A].

30.

Memorandum from David W. Ogden, Deputy Att’y Gen., to Selected United
States Att’ys, Investigations and Prosecutions in States Authorizing the
Medical Use of Marijuana (Oct. 19, 2009), http://www.justice.gov/sites/
default/files/opa/legacy/2009/10/19/medical-marijuana.pdf [http://perma.
cc/67YQ-LWZG] [hereinafter Ogden Memo].

31.

Memorandum from James M. Cole, Deputy Att’y Gen., to United States
Att’ys, Guidance Regarding the Odgen Memo in Jurisdictions Seeking to
Authorize Marijuana for Medical Use, (June 29, 2011), http://www.justice.
gov/sites/default/files/oip/legacy/2014/07/23/dag-guidance-2011-formedical-marijuana-use.pdf [http://perma.cc/PKN9-DYCS] [hereinafter
Cole Memo 2011].

32.

Memorandum from James M. Cole, Deputy Att’y Gen., to United States
Att’ys, Guidance Regarding Marijuana Enforcement, (Aug. 29, 2013),
http://www.justice.gov/iso/opa/resources/3052013829132756857467.pdf
[http://perma.cc/NBT6-CC85] [hereinafter Cole Memo 2013].

33.

Id.

34.

Id.

35.

Consolidated and Further Continuing Appropriations Act, 2015, Pub. L.
No. 113-235, § 538, 128 Stat. 2130, 2217 (2014).
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Justice will be unable to use any funds to prevent states “from
implementing their own State laws that authorize the use, distribution,
possession, or cultivation of medical marijuana.”36 This, in addition to
the Ogden and Cole memos, sends the message that Congress does not
think that the CSA should be enforced against medical marijuana users.
While the current federal policy towards medical marijuana is nonenforcement, marijuana remains illegal under the CSA. Enforcement
policies are subject to change with administrations, so, until the CSA
is amended, the federal government will retain the power to prosecute
violations of the CSA. As long as marijuana remains on Schedule I,
employers can argue that their drug-free workplace policies, likely
containing blanket prohibitions on illegal drugs, apply to medical marijuana users.

II. Workplace Drug Testing
Despite the quasi-legal status of marijuana, employers can still fire
medical marijuana users for positive drug tests. One of the strongest
criticisms against drug testing raised by medical marijuana users is that
urine tests, the most common form of drug tests, are not an indication
of marijuana impairment.37 A few hours after marijuana is ingested,
marijuana’s primary psychoactive ingredient, delta-9-tetrahydrocannabinol (THC),38 metabolizes into a non-psychoactive metabolite,
THC-COOH.39 Although the effects of the THC only last a few hours,
detectable levels of THC-COOH can remain in a marijuana user’s
system for over a month.40 This means that medical marijuana users
can fail drug tests even if they use marijuana off-site and the THC is
not active in their systems at work.41
The statute presented in this Note is not meant to prevent
employers from conducting drug tests of employees. Rather, its goal is
to protect employees from being punished for using a drug that may be
the best form of relief available for their conditions. The fact that drug
36.

Id.

37.

See Stacy A. Hickox, Drug Testing of Medical Marijuana Users in the
Workplace: An Inaccurate Test of Impairment, 29 Hofstra Lab. & Emp.
L.J. 273, 299 (2012).

38.

See Robert S. Goodwin et al., Urinary Elimination of 11-Nor-9-Carboxy-Δ9tetrahydrocannabinol in Cannabis Users During Continuously Monitored
Abstinence, 32 J. Analytical Toxicology 562, 562 (2008).

39.

People v. Feezel, 783 N.W.2d 67, 83 (Mich. 2010) (“[THC-COOH] is a
metabolite—a natural byproduct that is created when a person’s body
breaks down THC.”).

40.

See, e.g., Goodwin, supra note 38, at 567; Hickox, supra note 37, at 288.

41.

See Stacy A. Hickox, Clearing the Smoke on Medical Marijuana Users in
the Workplace, 29 Quinnipiac L. Rev. 1001, 1009 (2011).
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tests are a poor indicator of marijuana impairment strengthens the
argument that employers should not use positive drug tests to discriminate against medical marijuana users. Medical marijuana users require
protection because “[t]he imbalance of economic power gives employers
the ability to control more than is rightfully theirs.”42 The statute in
this Note attempts to correct that imbalance. Writing a fair statute,
however, requires an understanding of employers’ reasons for drug
testing employees. This section discusses employers’ reasons for drug
testing and explains how the proposed statute addresses those reasons.
Compliance with state and federal law is one reason that employers
drug test. For example, the federal Drug Free Workplace Act (DFWA)
imposes certain conditions on the receipt of federal contracts worth
more than $100,000 or federal grants of any value.43 Recipients must
promote a drug-free workplace, which includes informing employees
that use of controlled substances, even if legal under state law, will
result in actions taken against the employee.44 If an employer fails to
impose sanctions on employees that use controlled substances illicitly,
or if an employer fails to take any of the other required statutory
measures to promote a drug-free workplace, it can lose its federal grant
or contract.45 The DFWA does not explicitly require drug testing.
Nevertheless, an employer could not knowingly employ a medical
marijuana user under the DFWA because employees are prohibited
from “engaging in the unlawful . . . use of a controlled substance,” and
marijuana is an unlawful controlled substance.46
Employers of commercial motor vehicle operators must also drug
test employees to screen for controlled substances and alcohol.47 The
tests must be conducted before employment, at random, under reasonable suspicion, and after accidents.48 The Department of Transportation
does not make an exception to this policy for medical marijuana users.49
Similarly, the Federal Railroad Administration requires employers to

42.

Lewis L. Maltby & Bernard J. Dushman, Whose Life Is It Anyway—
Employer Control of Off-Duty Behavior, 13 St. Louis U. Pub. L. Rev. 645,
659 (1994).

43.

41 U.S.C. §§ 8102(a)(1), 8103(a)(1) (2012).

44.

41 U.S.C. §§ 8102–8103 (2012).

45.

Id.

46.

41 U.S.C. § 8101(a)(5)(B) (2012).

47.

49 U.S.C. § 31306(b) (2012).

48.

Id.

49.

See DOT ‘Medical’ Marijuana Notice, U.S. Dep’t of Transp. (Feb. 13,
2015), http://www.transportation.gov/odapc/medical-marijuana-notice
[https://perma.cc/K38N-83XW].
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drug test train and signal employees.50 Schedule I substances are
completely prohibited.51 Schedule II-V substances may be used if the
employee’s treating physician prescribed them at an authorized level
“consistent with the safe performance of the employee’s duties.”52 The
physician must be informed of certain relevant information, such as the
employee’s medical history, work duties, and other treating sources.53
The employee must use the prescription in accordance with the dosage
prescribed.54
Some state laws also require drug testing as a condition of
employment for certain employees, such as school bus drivers55 and
state contractors.56 Other state laws incentivize employers to drug test
employees by offering benefits to those that implement drug-free workplace policies. For example, Ohio offers workers’ compensation premium
rebates to employers that comply with the state’s drug-free safety
program, which requires drug testing employees.57
Even when the law does not require employers to drug test
employees, some choose to do so anyway. Some legal scholars have
noted that employers are concerned about the effect marijuana use has
on workplace safety, employee performance, and absenteeism.58 Quest
Diagnostics, a major drug testing provider to the government and
private sector, conducted approximately 6.6 million urine drug tests for

50.

49 C.F.R. § 219.601 (2014).

51.

49 C.F.R. § 219.102 (2014) (“No employee who performs covered service
may use a controlled substance at any time, whether on duty or off duty,
except as permitted by § 219.103.”).

52.

49 C.F.R. § 219.103 (2014).

53.

49 C.F.R. § 219.103(a)(1), (3) (2014).

54.

49 C.F.R. § 219.103(a)(2) (2014).

55.

See Alaska Stat. § 14.09.025 (2014) (requiring random drug testing of
school bus drivers); Ariz. Rev. Stat. Ann. § 15-513 (2014) (requiring
drug testing of school transportation authorities if there is “probable cause
that the employee’s job performance has been impaired by the use of
alcohol or a drug”).

56.

See La. Rev. Stat. Ann. § 49:1021(B) (Supp. 2015) (requiring the
commissioner of administration to “establish and administer a program
for random drug testing for all persons who receive anything of economic
value or receive funding from the state”).

57.

Ohio Admin. Code 4123-17-58 (Supp. 2014).

58.

See James M. Shore, Medical Marijuana and Zero Tolerance Drug Testing
Policies, Emp. Benefit Plan Rev., May 2011, at 6, 7; Deborah J. La Fetra,
Medical Marijuana and the Limits of the Compassionate Use Act: Ross v.
RagingWire Telecommunications, 12 Chap. L. Rev. 71, 73–74 (2008).
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employers in 2014.59 The fact that one company has conducted so many
tests indicates that drug testing is a prevalent employment issue.
The statutory language presented in this Note prohibits an
employer from discriminating against a medical marijuana user based
on a positive drug test, but exempts employers that are subject to the
DFWA or mandatory drug testing laws. This protects employers
seeking to comply with the law. The statute in this Note also exempts
medical marijuana users from protection if their marijuana use poses a
threat of harm to the workplace or interferes with their ability to
perform essential job duties. This protects employers seeking to discipline employees for poor performance. Both of these exemptions
alleviate the concerns that employers have about employing marijuana
users. Employers can still maintain their drug-free workplace policies
for recreational marijuana users and users of other illicit drugs. Medical
marijuana users are protected because employers cannot use positive
drug tests, which do not even indicate impairment, as evidence that the
users cannot adequately perform their jobs.

III. Court Responses to Conflicting Federal and
State Marijuana Laws
Some medical marijuana users have sought relief from the courts
after being fired for positive drug tests. The courts’ responses have
largely denied such relief. In every case, the employee (or prospective
employee) used medical marijuana off-site and was not impaired at
work. Nevertheless, in every case the courts upheld the employers’ right
to terminate their employees for marijuana use. The courts have ruled
in favor of the employers for two general reasons: (1) federal law
preempted any state law purporting to legalize marijuana use60 or (2)
the state medical marijuana statute did not address employment, and
thus did not remove an employer’s power to fire employees for using
marijuana.61

59.

Illicit Drug Positivity Rate Increases Sharply in Workplace Testing, Finds
Quest Diagnostics Drug Testing Index Analysis, Quest Diagnostics
(June 9, 2015), http://www.questdiagnostics.com/home/physicians/healthtrends/drug-testing.html [https://perma.cc/L3XP-BGWQ]. For an archived
list of Quest’s drug testing reports, see Drug Testing Index Archives,
Quest Diagnostics, http://www.questdiagnostics.com/home/physicians/
health-trends/drug-testing/archives.html [https://perma.cc/9ERP-PSJD]
(last visited Sept. 29, 2015).

60.

See Emerald Steel Fabricators, Inc. v. Bureau of Labor & Indus., 230 P.3d
518, 536 (Or. 2010).

61.

See, e.g., Roe v. Teletech Customer Care Mgmt. LLC, 257 P.3d 586, 590
(Wash. 2011); Ross v. RagingWire Telecomms., Inc., 174 P.3d 200 (Cal. 2008).
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A.

The Risk of Federal Preemption

If state medical marijuana laws are preempted by the CSA, then
they cannot protect medical marijuana users because they will be
“without effect.”62 In the CSA, Congress expressly stated that it did not
intend to “occupy the field in which [the CSA] operates.” 63 This means
that states may create their own drug laws. If, however, there is a
“positive conflict” between the CSA and state law “so that the two
cannot consistently stand together,” then the CSA will preempt the
state law.64 Conflict preemption exists in two situations: (1) when it is
physically impossible to comply with both federal and state law and (2)
when state law “stands as an obstacle” to Congress’s purpose.65
1.

State Courts Have Come to Different Decisions about Whether
Federal Law Preempts State Medical Marijuana Laws

While courts agree that medical marijuana laws do not make
compliance with the CSA impossible,66 they have come to differing conclusions about whether medical marijuana laws are an obstacle to the
accomplishment of the CSA’s purpose.67 To analyze this issue courts
use “two cornerstones of . . . pre-emption jurisprudence.”68 First is Congressional purpose.69 The CSA’s two main purposes, as identified by the
Supreme Court, are combatting drug abuse and controlling drug traffic-

62.

Maryland v. Louisiana, 451 U.S. 725, 746 (1981) (“The Supremacy Clause
provides that ‘[t]his Constitution, and the Laws of the United States which
shall be made in Pursuance thereof . . . shall be the supreme Law of the
Land . . . any Thing in the Constitution or Laws of any State to the Contrary
notwithstanding.’ It is basic to this constitutional command that all
conflicting state provisions be without effect.”) (internal citation omitted).

63.

21 U.S.C. § 903 (2012).

64.

Id.

65.

See, e.g., Emerald Steel, 230 P.3d at 528 (quoting Freightliner Corp. v.
Myrick, 514 U.S. 280, 287 (1995)); Arizona v. United States, 132 S. Ct. 2492,
2501 (2012).

66.

Medical marijuana laws only authorize marijuana use, they do not require
it. It is not impossible to comply with federal law and medical marijuana
laws because a person can choose to refrain from marijuana use. See, e.g.,
Emerald Steel, 230 P.3d at 528.

67.

Compare Emerald Steel, 230 P.3d 518 (holding that the Oregon Medical
Marijuana Act did not fail under an impossibility preemption analysis but
did fail under an obstacle preemption analysis), with White Mountain
Health Ctr. Inc. v. Cnty. of Maricopa, No. CV 2012-053585, 2012 WL
6656902 (Ariz. Sup. Ct. Dec. 3 2012) (holding that Arizona’s medical
marijuana act was not preempted by the CSA).

68.

Wyeth v. Levine, 555 U.S. 555, 565 (2009).

69.

Id.
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king.70 The second cornerstone is “the assumption that the historic
police powers of the States were not to be superseded by the Federal
Act unless that was the clear and manifest purpose of Congress.”71 Drug
policy has traditionally been a police power of the state,72 so medical
marijuana laws should be granted the presumption of validity.73
In Emerald Steel v. Bureau of Labor and Industries,74 the Oregon
Supreme Court held that the CSA intended to accomplish its objectives
through a blanket prohibition on marijuana.75 It does not matter if a
person purports to be using marijuana for medical purposes because
“by classifying marijuana as a Schedule I drug, Congress has expressed
its judgment that marijuana has no recognized medical use.”76 Thus, a
state law that authorizes marijuana use, for any reason, is an obstacle
to Congress achieving its goals in implementing the CSA.77 The dissent
did not think that Oregon’s medical marijuana law would contravene
the purpose of the CSA, especially in light of the federal government’s
pronouncement in the Ogden memo.78 The Ogden memo stated that the
federal government would “not enforce the [CSA] against ‘individuals
whose actions are in clear and unambiguous compliance with existing
state laws permitting the medical use of marijuana.’”79 Therefore, the
dissent argued, it is not the “clear and manifest purpose of Congress”80
to preempt state medical marijuana laws.81
70.

Gonzales v. Raich, 545 U.S. 1, 12 (2005); see also Todd Garvey & Brian
T. Yeh, Cong. Research Serv., R43034, State Legalization of
Recreational Marijuana: Selected Legal Issues 11 (2014) (noting
that the Supreme Court discussed the CSA’s purpose in Gonzales).

71.

Wyeth, 555 U.S. at 565 (quoting Medtronic, Inc. v. Lohr, 518 U.S. 470,
485 (1996)).

72.

Cole Memo 2013, supra note 32 (“[T]he federal government has
traditionally relied on states and local law enforcement agencies to address
marijuana activity through enforcement of their own narcotics laws.”).

73.

See Garvey & Yeh, supra note 70 at 11-12.

74.

230 P.3d 518 (Or. 2010).

75.

Id. at 529.

76.

Id.

77.

Id.

78.

Id. at 543 (Walters, J., dissenting) (citing Memorandum from David W.
Ogden, Deputy Att’y Gen., to Selected United States Att’ys, Investigations
and Prosecutions in States Authorizing the Medical Use of Marijuana
(Oct. 19, 2009), http://www.justice.gov/sites/default/files/opa/legacy/2009/
10/19/medical-marijuana.pdf).

79.

Id. (Walters, J., dissenting).

80.

Wyeth v. Levine 555 U.S. 555, 565 (2009) (quoting Medtronic, Inc. v. Lohr,
518 U.S. 470, 485 (1996)).

81.

Emerald Steel, 230 P.3d at 543 (Walters, J., dissenting).
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In concluding that the Arizona Medical Marijuana Act (AMMA)
was not preempted by the CSA, an Arizona trial judge noted that the
Oregon Supreme Court “stands virtually alone when it suggested that
almost any State statute that affirmatively authorizes federally conflicting conduct is preempted.”82 The Arizona judge argued that AMMA
actually “further[ed] the CSA’s objectives.”83 AMMA’s strict regulatory
regime ensured that marijuana was only used for medicinal purposes.84
Arizona’s other drug abuse prevention laws remained intact.85 AMMA
also created a registry of persons authorized to grow, sell, and use
medical marijuana.86 The registry makes people easy targets for federal
prosecutors, furthering the CSA’s goal of combatting drug trafficking.87
This Note argues that the Emerald Steel dissent and Arizona judge
present the stronger arguments. If Congress wished to enforce the CSA
against medical marijuana growers, sellers, and users it could easily do
so. But it has not. In fact, since those decisions, the Department of
Justice has released two more memos reinforcing its position that it will
not use the CSA to prosecute people who are complying with state
medical marijuana laws.88 And, at least for the 2015 fiscal year, enforcement of the CSA against medical marijuana users will be nonexistent
because Congress has deauthorized the use of federal funds for that
purpose.89 These developments strengthen the argument that Congress
does not have a clear intention to preempt medical marijuana laws with
the CSA.
2.

Federal Law Should Not Preempt a State’s Attempt to Provide
Employment Rights to Its Medical Marijuana Patients

A statute that accommodates employees that use medical
marijuana but includes exemptions to ensure that employers do not
violate federal law, should not be preempted by the CSA. The statute
presented in this Note passes the tests for both impossibility and
obstacle preemption. It will not be impossible for employers to comply
with this statute because it specifically exempts employers from

82.

White Mountain Health Ctr. Inc. v. Cnty. of Maricopa, No. CV 2012-053585,
2012 WL 6656902, at *8 (Ariz. Sup. Ct. Dec. 3, 2012).

83.

Id. at *6.

84.

Id.

85.

Id. at *7.

86.

Id. at *2.

87.

Id. at *8.

88.

Cole Memo 2011, supra note 31; Cole Memo 2013, supra note 32.

89.

Consolidated and Further Continuing Appropriations Act, 2015, Pub. L.
No. 113-235, § 538, 128 Stat. 2130, 2217.
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accommodating medical marijuana users when doing so would cause
the employer to violate a federal law or lose federal benefits.
The statute in this Note also does not stand as an obstacle to
Congress’s objectives in passing the CSA. The statute presented in this
Note is distinguishable from the statute at issue in Emerald Steel, which
was unenforceable on obstacle preemption grounds. In Emerald Steel,
the Oregon Supreme Court held that the provision of Oregon’s medical
marijuana act that authorized use of medical marijuana was preempted.90 The statute in this Note authorizes employment of medical
marijuana users. It is already unclear whether Congress intended the
CSA preempt medical marijuana use. Congressional intent regarding
employment of medical marijuana users is even less clear and certainly
not clear enough to supersede the traditional state powers to craft drug
policy.
The Emerald Steel decision was an outlier. Almost every case
regarding termination of medical marijuana users for a positive drug
test was decided on nonpreemption grounds. The courts in the cases
decided on nonpreemption grounds made suggestions about what an
appropriate employee protection statute would look like if the
legislature were to amend its state’s medical marijuana laws. This
suggests that those courts would enforce a properly drafted statute that
protects medical marijuana users. It is unlikely the statute proposed in
this Note would be preempted.
B.

Even If Not Preempted, State Medical Marijuana Statutes
Fail to Adequately Protect Employees

Even if not preempted, courts have consistently ruled that medical
marijuana laws do not create implied causes of action for employees
fired after positive drug tests.91 This means that, for the purposes of
workplace drug tests, licensed medical marijuana users are treated no
differently than illegal drug users. There is, however, language in both
90.

Emerald Steel Fabricators, Inc. v. Bureau of Labor & Indus., 230 P.3d 518,
536 (Or. 2010).

91.

See, e.g., Casias v. Wal-Mart Stores, Inc., 764 F. Supp. 2d. 914, 924 (W.D.
Mich. 2011) (“Michigan voters could not have intended to enact private
employment regulation implicitly, through a negative inference, when the
rights of employees are never mentioned anywhere else in the statute.”),
aff’d, 695 F.3d 428 (6th Cir. 2012); Roe v. Teletech Customer Care Mgmt.
LLC, 257 P.3d 586, 591–92 (Wash. 2011) (“The language of [Washington’s
medical marijuana law] is unambiguous—it does not regulate the conduct
of a private employer or protect an employee from being discharged
because of authorized medical marijuana use.”). Only a few states’ medical
marijuana statutes directly address the rights of employees. A medical
marijuana user has yet to challenge an employer in those states, so the
efficacy of their statutes remains unproven. See infra Part IV for a
discussion of these states’ statutes.
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the majority opinions and dissents that shows that courts would honor
employment rights for medical marijuana users if those rights were
expressly written into the medical marijuana law. The courts reveal,
through the opinions and dicta, what it would take for them to rule in
favor of the employees. This Note applies these lessons in drafting the
statute presented herein.
State courts are hesitant to create employment rights for medical
marijuana users for two primary reasons. First, doing so would violate
the will of the voters or legislatures that passed the laws. Under the
courts’ reasoning, if the voters or legislatures had wanted employment
protections for medical marijuana users, they would have included them
in the statutes authorizing marijuana use.92 Second, courts fear the
negative consequences that judicially created employment rights would
have on employers. For example, forcing employers to violate the
DFWA. 93
While court decisions thus far have been unfavorable for employees
that use medical marijuana, the courts have not foreclosed the
possibility that the laws could be amended to include employment
protections. The California Supreme Court said that, although marijuana is illegal under federal law, voters “were free to disagree with
Congress’s assessment of marijuana.”94 It went on to say that a medical
marijuana law with employment protections should provide notice to
employers that they must accommodate marijuana use.95 The Washington Supreme Court suggested that “any statute creating employment
protections for authorized medical marijuana users might include
exceptions for certain occupations or permissible levels of impairment
on the job.”96
The current case law demonstrates that courts will not find an implied cause of action for wrongful termination in an ambiguous medical
marijuana statute. Many state statutes could benefit from clearer
language addressing employment law. Some state statutes only provide
protection from arrest for authorized medical marijuana use.97 Others
92.

Roe, 257 P.3d at 594 (“[T]here is no evidence voters intended
[Washington’s medical marijuana law] to provide employment protections
or to prohibit an employer from discharging an employee for medical
marijuana use.”); Casias, 764 F. Supp. 2d at 926 (“If the voters of Michigan
meant to enact such sweeping legislation, they had to do so explicitly.”).

93.

Ross v. RagingWire Telecomms., Inc., 33 Cal. Rptr. 3d 803, 811 n.5 (Cal.
Ct. App. 2005), aff’d, 174 P.3d 200 (Cal. 2008).

94.

Ross, 174 P.3d at 205.

95.

Id. at 208–209.

96.

Roe, 257 P.3d at 593.

97.

Md. Code. Ann., Health–Gen. § 13-3313(a) (West Supp. 2014); Mass
Gen. Laws Ann. ch. 94C, § 1-4 (West Supp. 2014); Mich. Comp. Laws
Ann. § 333.26424(a) (West. Supp. 2015); Mont. Code Ann. § 50-46-
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do not prevent arrest but merely provide an affirmative defense to
prosecution.98 Many also state that nothing in the statute will “require
any employer to accommodate the medical use of marijuana in any
work place.”99 Based on how courts have interpreted statutes devoid of
employment provisions, employees would likely fail if they brought
wrongful termination suits in these states. These decisions underscore
the need for legislative action to protect medical marijuana users.

IV. Some State Medical Marijuana Statutes
Do Include Employment Provisions
The state medical marijuana statutes examined in this section have
provisions explicitly addressing employment. But the employment provisions have yet to be tested in court. The language in these provisions
provides ideas and guidance to those who wish to amend their states’
medical marijuana laws to include employment protections.
Rhode Island and Connecticut explicitly prohibit employers from
refusing to employ, or otherwise penalizing, employees solely for their
status as medical marijuana cardholders.100 Of the laws that address
employment, these are the least protective. They only protect the fact
that a person holds a medical marijuana card, not the fact that a person
may be using marijuana. If an employer in Rhode Island or Connecticut
fired an employee for a positive drug test the employee would find no
protection in the state’s law.101
319(2) (2013); N.J. Stat. Ann. § 24:6I-2(e) (West Supp. 2015); N.M.
Stat. Ann. § 26-2B-4(A) (West 2014); N.Y. Pub. Health Law § 3369
(McKinney 2014); Vt. Stat. Ann. tit. 18, § 4474b(a) (2013); Wash.
Rev. Code Ann. § 69.51A.040 (West 2014).
98.

Alaska Stat. § 17.37.030(a) (2012); Colo. Const. art. XVIII,
§ 14(2)(a)(III); Haw. Rev. Stat. § 329-125(a) (West 2014); Or. Rev. Stat.
Ann. § 475.319(1) (West Supp. 2014); D.C. Code § 7-1671.08(c) (2012).

99.

Colo. Const. art. XVII, § 14(10)(b). See also Haw. Rev. Stat. § 329122(c)(2)(B) (West 2014); Mass. Gen. Laws Ann. ch. 94C, § 1-7(D)
(West Supp. 2015); Mich. Comp. Laws Ann. § 333.26427(c)(2) (West
Supp. 2015); N.J. Stat. Ann. § 24-6I-14 (West Supp. 2015); N.M. Stat.
Ann. § 26-2B-5 (West 2014); Or. Rev. Stat. Ann. § 475.340(2) (West
2014); Vt. Stat. Ann. tit. 18, § 4474c(a)(1)(B) (West 2014); Wash.
Rev. Code Ann. § 69.51A.060(4) (West 2014).

100. 21 R.I. Gen. Laws Ann. § 21-28.6-4(c) (West 2014); Conn. Gen. Stat.
Ann. § 21a-408p(b)(3) (West 2015).
101. On November 12, 2014, the ACLU announced that it had filed a complaint
on behalf of a student who was denied employment because of her status as
a medical marijuana cardholder in Rhode Island, so that statute may be
tested soon. ACLU Files Suit Over Medical Marijuana Discrimination,
ACLU (Nov. 12, 2014), https://www.aclu.org/criminal-law-reform/aclu-files
-suit-over-medical-marijuana-discrimination [https://perma.cc/XVZ9-Q44C].
In August 2015, a Superior Court judge in Rhode Island denied the defendant
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Like Rhode Island and Connecticut, Illinois and Maine also prohibit
employers from refusing to employ, or otherwise penalizing, a person
based on his or her status as a cardholder, but these states add
additional protections for employers.102 For example, if accommodating
a person’s cardholder status would “put the . . . employer . . . in
violation of federal law or . . . cause it to lose a monetary or licensingrelated benefit under federal law,” the employer is excused from the
prohibition.103 Furthermore, Illinois explicitly allows employers to
enforce zero-tolerance or drug-free workplace policies “provided [that]
the policy is applied in a nondiscriminatory manner.”104 This means that
employers are free to discipline medical marijuana users for positive
drug tests as long as they also discipline other drug users in a similar
manner.
Arizona, Delaware, and Minnesota have similar employment
provisions, and these provisions provide the strongest protections for
employees (relative to other medical marijuana statutes).105 In addition
to prohibiting employers from discriminating against an employee for
his or her status as a cardholder, these states also prohibit employers
from discriminating against employees that test positive for marijuana
in a drug test.106 These provisions are subject to a few exceptions. First,
each of the three statutes includes an exception for employers that
would risk violating federal law or losing federal contracting money if
they accommodate medical marijuana users.107 Second, if an employee
uses or is impaired by marijuana while at the workplace they cannot
seek protection under these statutes.108

employer’s motion to dismiss. Katie Mulvaney, Judge Refuses to Dismiss
Medical Marijuana User’s Case Against RI Firm, Providence J. (Aug. 11,
2015), http://www.providencejournal.com/article/20150811/NEWS/150819900
[http://perma.cc/A463-55YR].
102. Me. Rev. Stat. Ann. tit. 22, § 2423-E (West 2014); 410 Ill. Comp.
Stat. Ann. 130/40(a)(1) (West Supp. 2015).
103. 410 Ill. Comp. Stat. Ann. 130/40(a)(1) (West Supp. 2015).
104. 410 Ill. Comp. Stat. Ann. 130/50(b)-(c) (West Supp. 2015).
105. Ariz. Rev. Stat. Ann. § 36-2813(B) (2014); Del. Code Ann. tit. 16,
§ 4905A(a)(3) (Supp. 2012); Minn. Stat. Ann. § 152.32(3)(c) (West 2014).
106. Ariz. Rev. Stat. Ann. § 36-2813(B)(2) (2014); Del. Code Ann. tit.
16, § 4905A(a)(3)(b) (Supp. 2014); Minn. Stat. Ann. § 152.32(3)(c)(2)
(West Supp. 2015).
107. Ariz. Rev. Stat. Ann. § 36-2813(B) (2014); Del. Code Ann. tit. 16,
§ 4905A(a)(3) (Supp. 2014); Minn. Stat. Ann. § 152.32(3)(c) (West
Supp. 2015).
108. Ariz. Rev. Stat. Ann. § 36-2813(B)(2) (2014); Del. Code Ann. tit.
16, § 4905A(a)(3)(b) (Supp. 2014); Minn. Stat. Ann. § 152.32(3)(c)(2)
(West Supp. 2015).
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New York is unique in that its medical marijuana statute does not
expressly create employment rights for medical marijuana users, but
rather it protects employees indirectly by specifying that users are
considered disabled for the purposes of the state’s disability discrimination law.109 As with many other medical marijuana law employment
provisions, there are exceptions allowing employers to enforce policies
that prohibit employees from working while impaired.110 Employers are
also exempt if compliance would cause them to violate federal law or
risk forfeiting a federal contract or funding.111
A recurring theme throughout the employment discrimination
provisions in state medical marijuana laws is that employees cannot be
“impaired” at work.112 Impairment is a broad term. For example, in
Arizona, symptoms that indicate drug impairment include the
following:
[T]he employee’s speech, walking, standing, physical dexterity,
agility, coordination, actions, movement, demeanor, appearance,
clothing, odor, irrational or unusual behavior, negligence or
carelessness in operating equipment, machinery or production or
manufacturing processes, disregard for the safety of the employee
or others, involvement in an accident that results in serious
damage to equipment, machinery or property, disruption of a
production or manufacturing process, any injury to the employee
or others or other symptoms causing a reasonable suspicion of the
use of drugs or alcohol.”113

Illinois’ impairment definition uses similar language.114 This type of
“essentially tautological definition provides relatively little practical
guidance for employers facing difficult decisions concerning the

109. N.Y. Pub. Health Law § 3369(2) (McKinney 2014).
110. Id.
111. Id.
112. See, e.g., N.Y. Pub. Health Law § 3369(2) (McKinney 2014); Ariz.
Rev. Stat. Ann. § 36-2813(B)(2) (2014); Del. Code Ann. tit. 16,
§ 4905A(a)(3)(b) (Supp. 2014); Minn. Stat. Ann. § 152.32(3)(c)(2)
(West Supp. 2015).
113. Ariz. Rev. Stat. Ann. § 23-493(7) (2015).
114. Illinois’ definition of impairment includes “specific, articulable symptoms while
working that decrease or lessen [the employee’s] performance . . . including
symptoms of the employee’s speech, physical dexterity, agility, coordination,
demeanor, irrational or unusual behavior.” 410 Ill. Comp. Stat. Ann. 130/50(f)
(West Supp. 2015).
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employment of medical marijuana users.”115 Also, while the statute
names symptoms that are indicative of drug use, some symptoms (like
appearance and odor) do not necessarily indicate impairment.
Finally, Nevada’s statute requires that employers “make reasonable
accommodations” for employees that use medical marijuana as long as
the accommodations would not (1) “[p]ose a threat of harm or danger
to persons or property,” (2) “impose an undue hardship on the employer,” or (3) “[p]rohibit the employee from fulfilling any and all of his
or her job responsibilities.”116 This is unique in two ways. First, it does
not include the problematic impairment language included in the other
states’ medical marijuana statutes. Rather, its narrower language requires employers to show that the employee poses a threat to the work
place. An employer is justified in firing an employee that poses such a
threat. Under the statutes that use the term “impairment,” an employer
may be permitted to fire an employee that simply shows the physical
signs of impairment (like smell or red eyes) without having to show
that the employee’s marijuana use poses some threat to the work place.
Second, Nevada’s statute does not specifically mention federal
contracting or compliance with federal drug-free workplace laws,
covering those concerns instead under the “undue hardship” provision.
The problem with this provision is similar to the problem with the
impairment provision—its broad language invites litigation. Because
the statutes do not clarify what an “undue hardship” is, the term will
have to be clarified in court if litigation ever arises. Clearer language
will reduce litigation costs by making it clear to employees when their
employers have the right to fire them.

V. Statute Recommendation
The statute presented in this Part addresses the rights of medical
marijuana cardholders. For the purposes of this statute, as well as many
states’ medical marijuana statutes, a “cardholder” is a qualifying
patient or a designated caregiver who has been issued a valid registry
identification card by the state to possess, use, or cultivate marijuana.117
Patients are authorized to use marijuana. Caregivers are not authorized
to use marijuana, but they are authorized to possess it for patients.
115. Michael D. Moberly & Charitie L. Hartsig, Smoke—And Mirrors?
Employers and the Arizona Medical Marijuana Act, Ariz. Att’y,
July/Aug. 2011, at 30.
116. Nev. Rev. Stat Ann. § 453A.800(3) (West 2014).
117. See, e.g., 21 R.I. Gen. Laws Ann. § 21-28.6-3 (West 2014); Del. Code Ann.
tit. 16, § 4902A(1) (West Supp. 2014) (both defining a cardholder as a
qualifying patient or designated caregiver with a valid registry identification
card). See also Ariz. Rev. Stat. Ann. § 36-2801 (2014) (including nonprofit
medical marijuana dispensary agent in the definition of “cardholder”).
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Because patients are the people actually using marijuana, their rights
are addressed more thoroughly in this statute.
A.

Statute Language

Based on the recommendations in the case law and the provisions
in other states’ statutes, I propose that the following language be added
to medical marijuana statutes:
§ X. Employment
Cardholders.

Protections

for

Medical

Marijuana

(a) Unless failure to do so would cause an employer to lose a
monetary or licensing-related benefit under federal law or
regulations, an employer shall not discriminate against a person
in hiring, termination, or any condition of employment, or
otherwise penalize a person, based upon either of the following:
(1) That person’s status as a cardholder; or
(2) A patient’s medical use of marijuana, unless the patient
ingested or possessed marijuana on the premises of the workplace
or during work hours, without the written permission of that
patient’s employer.
(b) Section (a) of this provision shall not protect a patient whose
medical use of marijuana either:
(1) Poses an actual threat of harm or danger to persons or
property; or
(2) Makes the patient incapable of performing essential job duties.
(c) Employers shall be exempt from Section (a) to the extent
required to comply with state drug testing laws or regulations.
(d) Employers not exempt from Section (a) shall not be denied
any benefit for employing the persons identified in Sections (a)(1)
and (a)(2).
B.

Statute Analysis

This statutory language combines the best features of existing
medical marijuana statute employment provisions. It also takes into
account the lessons from state courts on what makes an appropriate
statute. It explicitly puts employers on notice that they cannot fire
employees just for using medical marijuana. And it puts employees on
notice that they can be fired if their medical marijuana use negatively
affects their performance or puts the workplace in danger. This section
discusses the purpose and effect of each part of the statute and how the
statute improves upon existing law.
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1.

Section (a)—Who and What is Protected by this Statute

Section (a) of this statute describes who is protected by the statute
and what activity constitutes employment discrimination against them.
The statute begins with a clause that exempts employers that would
violate federal laws like the DWFA if they employed medical marijuana
users. Most states with employment provisions in their medical
marijuana statutes have a similar provision. This language protects
employers and helps the statute withstand a preemption challenge. If
the law required employers to violate federal law, it would be without
effect under an impossibility preemption analysis.
The statute then describes what constitutes employment
discrimination under this provision. Employers can not consider a
person’s cardholder status or medical marijuana use when making
decisions about hiring, termination, or any other condition of employment (like salary or benefits). “[O]r otherwise penalize a person” is a
catchall phrase, found in many states’ employment provisions. It
ensures that patients and caregivers are fully protected from any kind
of discrimination.
Medical marijuana cardholders are protected in two specific ways
by the statute. First, a cardholder’s status is fully protected by the
statute by Section (a)(1). That means that an employer cannot fire
someone simply because that person is licensed under a state medical
marijuana law. Unlike a positive drug test, being a cardholder does not
necessarily indicate marijuana use. Allowing employers to fire people
solely for their status as cardholders would be baseless and unfair.
Licensed patients, growers, sellers, caregivers, and other cardholders all
benefit from Section (a)(1).
Section (a)(2) protects an employee’s medical use of marijuana. But
an employee’s use of marijuana is only protected if two conditions are
met: (1) the employee is a patient, and (2) the employee does not
possess or ingest marijuana at the place of employment or during work
hours without written permission. This section requires an employee to
be a patient because patients are the only types of cardholders that are
authorized to use marijuana.
Section (a)(2) also specifically says that employees cannot “ingest”
marijuana at work. Although some statutes say that an employee may
not “use” or “smoke” medical marijuana while at work, those words are
inadequate. “Use” is too broad of a term. In Coats v. Dish Network,
LLC,118 the employer argued that the word “use” included situations in
which the employee, Brandon Coats, consumed marijuana off-duty and
off-premises.119 The employer cited Coats’ opening brief, which stated
118. 350 P.3d 849 (Colo. 2015).
119. Answer Brief at 6, Coats v. Dish Network, LLC, 350 P.3d 849 (Colo. 2015)
(No. 11-CV-1464).
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that Coats’s medical marijuana use “decreased painful muscle spasms,
allowing Coats to work.”120 Because “he was using [medical marijuana]
to control his symptoms at work, he was ‘medically using’ marijuana
on-duty, on-premises.”121 If a court accepted that argument, an
employee would not be protected by a statute that barred “use” of
marijuana at work. “Smoke” has a different problem—it is too narrow
of a word. Marijuana can be vaporized, eaten, used as a tincture, or
ingested in other ways. Thus, this statute uses the word “ingest,” which
the Merriam-Webster dictionary defines as “to take (something, such
as food) into your body.”122 This word is broad enough (unlike the word
“smoke”) to encompass all forms of marijuana consumption, yet narrow
enough (unlike the word “use”) to require that the employee actually
take the marijuana in the work place or during work hours.
Provisions allowing employers to bar use of marijuana in the
workplace are standard in state medical marijuana laws. This statute
adds special language that allows employees to use marijuana with the
employer’s permission. Requiring the employee to obtain written
permission protects both employers and employees by creating
documentation of any permission the employee receives. If the employee
is later terminated for using or possessing marijuana at work, the
documentation, or lack thereof, could be dispositive for the case.
2.

Section (b)—When Medical Marijuana Use Is Not Protected by this
Statute

Section (b) addresses employers’ interests in workplace safety and
employee performance. It allows employers to achieve the same goals
as drug testing—keeping dangerous and incapable employees out of the
workplace. But it also protects medical marijuana users from being fired
when their marijuana use has no negative effect on their job. Although
many states exempt employees that are “impaired” at work from protection, this statute uses narrower language. The narrower language
allows the statute to reduce the risk that an employee will be fired for
an arbitrary reason while still accomplishing the ultimate purpose of
impairment language—keeping negative effects of drug use out of the
workplace.
Section (b)(1) treats medical use of marijuana like prescription drug
use. Even though their drugs are legal under both state and federal law,
prescription drug users can face discipline if their drug use threatens
the workplace. For example, railroad employees can only use
120. Id. (quoting Opening Brief at 51, Coats v. Dish Network, LLC, 350 P.3d 849
(Colo. 2015) (No. 11-CV-1464)).
121. Id.
122. Dictionary—Ingest, Merriam-Webster, http://www.merriam-webster.com/
dictionary/ingest [http://perma.cc/CGP5-C2Q4] (last visited Oct. 1, 2015).
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prescription drugs if they can do so in a way that is “consistent with
the safe performance” of their employment duties.123 Similarly, the ADA
permits employers to fire employees whose prescription drug use poses
a “direct threat to the health or safety of other individuals in the
workplace.”124 Section (b)(2) precludes employees from using marijuana
use as an excuse for failing to perform up to standards. Its language is
also similar to that of the ADA: The ADA requires a claimant to be
able to perform “essential functions of the employment position that
such individual holds or desires.”125
While employers use generalizations about marijuana to justify
workplace drug policies, marijuana’s effects vary widely based on
factors such as the user’s tolerance, dosage, type of marijuana used, and
method of ingestion.126 Sections (b)(1) and (b)(2) protect medical marijuana users from these generalizations by ensuring them the right to an
individualized assessment.127
An employer could not cite to Section (b) as a reason to not hire
an applicant. Before employment, a medical marijuana user has yet to
threaten the workplace or perform poorly. In many states, employers
can fire medical marijuana users because the employers fear the effects
that marijuana might have on the user. This statute requires that the
marijuana actually have an effect. Mere knowledge that an employee
uses medical marijuana is not a sufficient reason for termination.
3.

Section (c)—Respecting State Drug Testing Laws

Section (c) ensures that this provision does not displace state drug
testing laws. Like the federal government, states also mandate drug
testing for certain employees. For example, Connecticut requires drug
testing of school bus drivers and other employees that serve in “highrisk or safety-sensitive” occupations.128 If a state adopts the statute
proposed in this Note, then it should amend Section (c) to expressly
state which state drug testing laws supersede this statute. This would
put employers and employees on notice about how to comply with this
statute.
Section (c) allows employers to violate Section (a) (which prohibits
employers from taking adverse action against medical marijuana users)
when employers must comply with state drug testing laws. If it did not,
123. 49 C.F.R. § 219.103 (2014).
124. 42 U.S.C. § 12113(b) (2012).
125. 42 U.S.C. § 12111(8) (2012).
126. Report, supra note 15, at 61–63.
127. See Hickox, supra note 41, at 1045 (“Under the ADA, the employer’s
proof that an individual poses a ‘direct threat’ must be based on an
‘individualized assessment of the individual’s present ability to safely
perform the essential functions of the job.’”).
128. Conn. Gen. Stat. Ann. § 31-51x (West Supp. 2015).
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then employers face an impossible choice when their employees used
medical marijuana—fire the employee and risk violating this statute or
adhere to this statute and violate state law.
4. Section (d)—Additional Protection for Employers

Section (d) protects employers from medical marijuana related
discrimination. It ensures that compliance with this statute, which
restricts the situations in which an employer may fire or otherwise discipline medical marijuana users, will not cause the employer any
detriment. States and insurance companies may attempt to encourage
zero-tolerance workplace drug policies by offering benefits to employers
that enforce them. With Section (d), an employer could not be denied
any benefit for refusing to take adverse action against an employee
(assuming the employer adhered to the other conditions attached to the
benefits).

Conclusion
The terminated medical marijuana users mentioned at the
beginning of this Note—Gary Ross, Joseph Casias, Brandon Coats—
could have vindicated their rights in court if their states’ medical
marijuana laws had contained the statutory language proposed in this
Note. Unfortunately many states’ medical marijuana laws still lack
employment provisions. This Note recommends that states adopt the
proposed statutory language into their medical marijuana laws.
The CSA’s classification of marijuana as a Schedule I substance has
been attacked since its inception. The National Commission on
Marihuana and Drug Abuse, whose creation was mandated by the CSA,
was the first to disagree with the classification. In 1972, the Commission
found that “[m]arihuana’s relative potential for harm to the vast
majority of individual users and its actual impact on society does not
justify a social policy designed to seek out and firmly punish those who
use it.”129 Since then, even more research has shown that marijuana
should not be classified as a Schedule I substance.
Almost twenty years have passed since California enacted the
nation’s first medical marijuana law.130 In that time, twenty-two other
states and Washington, D.C. have also enacted medical marijuana
laws.131 Enforcement of the CSA against medical marijuana users is
weak. The Department of Justice has released several memos stating
129. Report, supra note 15, at 163.
130. California voters passed the state’s medical marijuana law in 1996. State
Medical Marijuana Laws, Nat’l Conf. of State Legislatures (Aug.
11, 2015), http://www.ncsl.org/research/health/state-medical-marijuana
-laws.aspx [http://perma.cc/SQQ4-ACU3].
131. Id.
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that it will not target state law–compliant medical marijuana users.
Also, Congress’s spending bill for the 2015 fiscal year prohibits the
Department of Justice from interfering with state medical marijuana
laws.132 Non-enforcement of the CSA lends strength to the argument
that the CSA would not preempt a state statute protecting medical
marijuana users’ employment rights. Also, unlike the statute preempted
in Emerald Steel, this statute would not be preempted because it only
authorizes employment of medical marijuana users, not use of
marijuana.133
The conflict between state and federal marijuana laws causes
confusion for employers, who are unsure whether state medical
marijuana laws supersede their power to enforce drug-free workplace
policies against employees.134 Courts consistently rule in favor of
employers when medical marijuana users challenge drug-free workplace
policies, but they have not foreclosed the possibility that state medical
marijuana laws could protect employees. Nevertheless, without explicit
statutory guidance, the courts will not recognize these rights. A state’s
medical marijuana statute should clearly address the scope of accommodation that employers must provide to medical marijuana users.
With this provision in their states’ medical marijuana laws, courts
could not dismiss an employee’s complaint for failure to state a claim
on the grounds that the language of the medical marijuana law “does
not regulate the conduct of a private employer or protect an employee
from being discharged because of authorized medical marijuana use.”135
This provision puts both employers and employees on notice about the
scope of an employer’s duty to accommodate medical marijuana use.
The statute in this Note protects medical marijuana users but not
recreational marijuana users (even if they are using the drug in
compliance with state law). The reason for this distinction is that
medical users rely on marijuana to alleviate symptoms of disabilities.
Current law forces medical users to choose between pain relief and
132. Consolidated and Further Continuing Appropriations Act, 2015, Pub. L.
No. 113-235, § 538, 128 Stat. 2130, 2217 (2014).
133. Emerald Steel Fabricators, Inc. v. Bureau of Labor & Indus., 230 P.3d
518 (Or. 2010). For a discussion of the Emerald Steel obstacle preemption
analysis, see supra Part III.A.i.
134. “[M]any employers lack a clear understanding of how to treat medical
marijuana users.” Hickox, supra note 41, at 1004 (2011) (surveying employers
about why they drug test and the consequences for positive drug tests).
135. Roe v. Teletech Customer Care Mgmt. LLC, 257 P.3d 586, 591–92 (Wash.
2011). See also Ross v. RagingWire Telecomms., Inc., 174 P.3d 200, 207 (Cal.
2008) (holding that “given the controversy that would inevitably have attended
a legislative proposal to require employers to accommodate marijuana use, we
do not believe that [California’s medical marijuana law] can reasonably be
understood as adopting such a requirement silently and without debate.”).
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employment. Recreational users, on the other hand, do not have to
make that choice. The statute in this Note does as much as possible to
eliminate the risk that medical marijuana users will face that choice.
States have finally given people suffering from illness and disability
access to a drug that can help them feel better—marijuana. But some
risk their jobs if they use it, even if that use is off-site and does not
affect the workplace. The ideas in this Note could be used to expand
the rights of medical marijuana users in the fields of housing, education,
parenting, and other areas. The courts have made it clear that state
medical marijuana laws need to provide these rights explicitly.
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